Get started
Author

Takafumi Minami

Observed names: MINAMI, Takafumi, Minami, Takafumi, T Minami, T. Minami, TAKAFUMI MINAMI, Takafumi MINAMI
Observed institutions: Kurume University, Jikei University School of Medicine, Shimane University, Kindai University Hospital, Kindai University Sakai Hospital, Kindai University
ORCID: 0000-0002-6934-3760
Observed ORCID: 0000-0002-6934-3760
OpenAlex ID: A5022626501
A Phase 2 Randomized Controlled Trial of Personalized Peptide Vaccine Immunotherapy with Low-dose Dexamethasone Versus Dexamethasone Alone in Chemotherapy-naive Castration-resistant Prostate Cancer
2016 · Kazuhiro Yoshimura, Takafumi Minami, et al. · European Urology · 89
PDF
The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome
2023 · Kazutoshi Fujita, Makoto Matsushita, et al. · Cancers · 63
PDF
Identification of Programmed Death Ligand 1–derived Peptides Capable of Inducing Cancer-reactive Cytotoxic T Lymphocytes From HLA-A24+ Patients With Renal Cell Carcinoma
2015 · Takafumi Minami, Tomoko Minami, et al. · Journal of Immunotherapy · 46
Trop-2 in Upper Tract Urothelial Carcinoma
2022 · Eisuke Tomiyama, Kazutoshi Fujita, et al. · Current Oncology · 45
PDF
Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma
2013 · K Yoshimura, T Minami, et al. · British Journal of Cancer · 40
PDF
Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study
2023 · Wataru Fukuokaya, Yuhei Koike, et al. · International Journal of Urology · 33
Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles
2006 · Takafumi Minami, Satoko Matsueda, et al. · Cancer Immunology Immunotherapy · 32
PDF
Transfection of poly(I:C) can induce reactive oxygen species-triggered apoptosis and interferon-β-mediated growth arrest in human renal cell carcinoma cells via innate adjuvant receptors and the 2-5A system
2014 · Nanae Harashima, Takafumi Minami, et al. · Molecular Cancer · 31
PDF
Sorafenib rechallenge in patients with metastatic renal cell carcinoma
2012 · Masahiro Nozawa, Yutaka Yamamoto, et al. · British Journal of Urology · 31
Comparison of molecular profiles of upper tract urothelial carcinoma vs. urinary bladder cancer in the era of targeted therapy: a narrative review
2022 · Eisuke Tomiyama, Kazutoshi Fujita, et al. · Translational Andrology and Urology · 28
PDF
Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective study
2022 · Taigo Kato, Kazutoshi Fujita, et al. · International Journal of Clinical Oncology · 24
Immunohistochemical Analysis of HER2, EGFR, and Nectin-4 Expression in Upper Urinary Tract Urothelial Carcinoma
2022 · MAMORU HASHIMOTO, KAZUTOSHI FUJITA, et al. · Anticancer Research · 23
PDF
Pazopanib for recurrent extraosseous E wing's sarcoma of the retroperitoneum
2014 · Yutaka Yamamoto, Masahiro Nozawa, et al. · International Journal of Urology · 21
Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer
2015 · Yutaka Yamamoto, Marco A De Velasco, et al. · Journal of Translational Medicine · 20
PDF
A novel radiation-shielding undergarment using tungsten functional paper for patients with permanent prostate brachytherapy
2018 · Masahiro Inada, Hajime Monzen, et al. · Journal of Radiation Research · 19
PDF
Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan Consortium
2024 · Taizo Uchimoto, Kengo Iwatsuki, et al. · International Journal of Clinical Oncology · 18
Predictive factors for the efficacy of abiraterone acetate therapy in high-risk metastatic hormone-sensitive prostate cancer patients
2022 · Takashi Ueda, Kazutoshi Fujita, et al. · World Journal of Urology · 17
External beam radiotherapy combination is a risk factor for bladder cancer in patients with prostate cancer treated with brachytherapy
2023 · Takafumi Minami, Kazutoshi Fujita, et al. · World Journal of Urology · 14
Efficacy of silodosin in patients undergoing brachytherapy: a randomized trial involving a pressure flow study
2014 · Nobutaka Shimizu, Takafumi Minami, et al. · World Journal of Urology · 14
Targeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancer
2022 · Yujiro Hayashi, Kazutoshi Fujita, et al. · Scientific Reports · 13
PDF
Higher neutrophil-to-lymphocyte ratio after the first cycle of the first-line chemotherapy is associated with poor cancer specific survival of upper urinary tract carcinoma patients
2021 · Mamoru Hashimoto, Kazutoshi Fujita, et al. · Translational Andrology and Urology · 12
PDF
Hypoxia-inducing factor (HIF)-1α-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma
2017 · Takafumi Minami, Naoki Matsumura, et al. · International Immunopharmacology · 12
Efficacy of Ramelteon in Patients with Insomnia and Nocturia
2012 · Nobutaka SHIMIZU, Koichi SUGIMOTO, et al. · LUTS Lower Urinary Tract Symptoms · 12
PDF
Screening for Predictive Factors of Efficacy of Second‐Generation Androgen Receptor Axis‐Targeted Agents in Patients With High‐Risk Metastatic Hormone‐Sensitive Prostate Cancer
2025 · Takashi Ueda, Keita Hayakawa, et al. · The Prostate · 11
Current status and future perspectives of the managements of metastatic hormone-sensitive prostate cancer
2022 · Naoki Matsumura, Kazutoshi Fujita, et al. · World Journal of Urology · 11
Works count: 118
Citation count: 855
H-index: 17
I10-index: 26
Year
Topic
Type